Antitope will use its Composite Human Antibody technology to generate mAbs for inflammatory and autoimmune diseases for NasVax

Antitope Ltd.

U.K. / Tools, Services, and Manufacturing

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

NasVax Ltd.

Israel / Small-Cap Biopharma (<$1 billion)

Other

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced